Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. (Q51484788)
Jump to navigation
Jump to search
scientific article published in December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. |
scientific article published in December 2006 |
Statements
1 reference
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. (English)
1 reference
Bernard Charbonnel
1 reference
Avraham Karasik
1 reference
Ji Liu
1 reference
Mei Wu
1 reference
Gary Meininger
1 reference
Sitagliptin Study 020 Group
1 reference
1 December 2006
1 reference
1 reference
29
1 reference
2638-2643
1 reference
12
1 reference
Identifiers
1 reference
1 reference